Schering-Plough submits NDAs for desloratadine

Sepracor (SEPR) partner Schering-Plough (SGP) submitted

Read the full 66 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE